Translational research has revolutionized how we develop new treatments for cancer patients. reflected in the increasing number of basket trials selecting specific molecular targets. Nonetheless, some weaknesses need to be addressed. The complexity of cancer cells enriched with concomitant molecular alterations complicates identification of the driver. Moreover, tumor heterogeneity could be responsible for the lack… Continue reading Translational research has revolutionized how we develop new treatments for cancer patients